Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Malignant Neoplasm
75%
Colorectal Carcinoma
69%
Neoplasm
67%
Cetuximab
49%
Dimer
46%
Chemotherapy
40%
Clinical Trial
39%
Biological Marker
38%
Heterodimer
36%
Oxaliplatin
36%
Fluorescence-Lifetime Imaging Microscopy
34%
Progression Free Survival
32%
Diseases
32%
Cancer Model
30%
Thioredoxin Interacting Protein
29%
Growth Differentiation Factor 15
29%
Mammalian Target of Rapamycin Inhibitor
29%
Prostate Cancer
29%
Head and Neck Cancer
29%
Breast Cancer
27%
Carcinogenesis
22%
CD8 Antigen
22%
Protein Kinase B
21%
Lung Cancer
19%
Protein Tyrosine Kinase Inhibitor
18%
Phosphotransferase
18%
Combination Therapy
18%
Non Small Cell Lung Cancer
17%
Colon Carcinoma
17%
Receptor
17%
Basal Like Breast Cancer
15%
Overall Survival
15%
Metastatic Breast Cancer
14%
Melanoma
14%
Recurrent Disease
14%
Immunogenicity
14%
Liposome
14%
Nanoparticle
14%
Fluorine 18
14%
Polyethylene Terephthalate
14%
Squamous Cell Carcinoma
14%
Head and Neck Squamous Cell Carcinoma
14%
Sapitinib
14%
Osimertinib
14%
Cancer Growth
14%
Drug Action
14%
Biodistribution
14%
Triple Negative Breast Cancer
14%
Phosphatidylinositol 3 Kinase
14%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
85%
Fluorescence-Lifetime Imaging Microscopy
73%
Energy Transfer
69%
Fluorescence Resonance Energy Transfer
58%
Dimerization
55%
Clinical Trial
53%
Protein Interaction
43%
Kinase
41%
Phosphotransferase
41%
Carcinogenesis
36%
Cetuximab
34%
Progression Free Survival
32%
Cancer Cell
31%
Growth Differentiation Factor
29%
Thioredoxin
29%
Protein Kinase B
29%
Fluorescence Anisotropy
25%
CD8
19%
Conformation
19%
CD14
19%
CD33
19%
Cell Membrane
19%
Small Molecule
18%
Steady State
18%
Internalization
18%
Protein-Protein Interaction
17%
Adenosine Triphosphate
15%
Overall Survival
15%
T Cell
15%
Interaction Study
14%
Substrate Interaction
14%
Molecular Interaction
14%
High Throughput Sequencing
14%
PD-L1
14%
Genomics
14%
Radiation Biology
14%
Ezrin
14%
in Vivo Gene Transfer
14%
Phosphoinositide 3-Kinase
14%
Lapatinib
14%
Tumor Marker
14%
Competitive Inhibition
14%
Cytokine
14%
STAT5
14%
Immunogenicity
14%
Dynamics
14%
Tumor Progression
14%
Lifespan
11%
Regulatory T Cell
10%
Actin
9%
Medicine and Dentistry
Epidermal Growth Factor Receptor
65%
Breast Cancer
50%
Colorectal Carcinoma
48%
Neoplasm
44%
Fluorescence-Lifetime Imaging Microscopy
41%
Oxaliplatin
36%
Heterodimer
36%
Clinical Trial
36%
Cetuximab
35%
Progression Free Survival
32%
Head and Neck Cancer
29%
Systemic Therapy
29%
Thioredoxin Interacting Protein
29%
Growth Differentiation Factor 15
29%
Biological Marker
26%
Dimer
25%
Targeted Therapy
25%
Diseases
25%
Energy Transfer
24%
Cancer Research
24%
Metastatic Carcinoma
23%
Basal Like Breast Cancer
19%
Cancer Cell
19%
Cancer Therapy
18%
Carcinogenesis
18%
Non Small Cell Lung Cancer
15%
Overall Survival
15%
Recurrent Disease
14%
Immunosuppressive Treatment
14%
Fluorine-18
14%
Tumour Heterogeneity
14%
Cancer Treatment
14%
Metastatic Breast Cancer
14%
Liposome
14%
Positron Emission Tomography
14%
Molecularly Targeted Therapy
14%
Melanoma
14%
Programmed Death-Ligand 1
14%
in Vivo Gene Transfer
14%
Protein Interaction
14%
Radiation Biology
14%
Squamous Cell
14%
Drug Action
14%
Complex Formation
14%
Signal Transduction
14%
Immunogenicity
14%
Biological Functions
14%
Neck
14%
Head and Neck Squamous Cell Carcinoma
14%
Receptor Family
14%
